share_log

This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

這位星座品牌分析師以看好的態度開始了覆蓋,以下是週五的五大啓動。
Benzinga ·  12/06 21:17

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖,請參閱我們的分析師評級頁面。

  • Needham analyst Gerald Pascarelli initiated coverage on Constellation Brands, Inc. (NYSE:STZ) with a Buy rating and announced a price target of $280. Constellation shares closed at $239.50 on Thursday. See how other analysts view this stock.
  • Jefferies analyst Maury Raycroft initiated coverage on Mereo BioPharma Group plc (NASDAQ:MREO) with a Buy rating and announced a price target of $7. Mereo BioPharma shares closed at $3.47 on Thursday. See how other analysts view this stock.
  • JP Morgan analyst Rohin Patel initiated coverage on Haemonetics Corporation (NYSE:HAE) with an Overweight rating and announced a price target of $116. Haemonetics shares closed at $80.67 on Thursday. See how other analysts view this stock.
  • Raymond James analyst Rick Patel initiated coverage on Abercrombie & Fitch Co. (NYSE:ANF) with an Outperform rating and announced a price target of $180. Abercrombie & Fitch shares closed at $149.95 on Thursday. See how other analysts view this stock.
  • UBS analyst Danielle Antalffy initiated coverage on Glaukos Corporation (NYSE:GKOS) with a Buy rating and announced a price target of $182. Glaukos shares closed at $135.70 on Thursday. See how other analysts view this stock.
  • Needham分析師Gerald Pascarelli對星座品牌公司(紐交所:STZ)進行了覆蓋,給予買入評級,並宣佈了280美元的目標價。星座品牌的股價在週四收盤時爲239.50美元。看看其他分析師如何看待這隻股票。
  • Jefferies分析師Maury Raycroft對mereo biopharma集團(納斯達克:MREO)進行了覆蓋,給予買入評級,並宣佈了7美元的目標價。mereo biopharma的股價在週四收盤時爲3.47美元。看看其他分析師如何看待這隻股票。
  • 摩根大通分析師Rohin Patel對美國血液技術公司(紐交所:HAE)進行了覆蓋,給予超配評級,並宣佈了116美元的目標價。美國血液技術的股價在週四收盤時爲80.67美元。看看其他分析師如何看待這隻股票。
  • Raymond James分析師Rick Patel對Abercrombie & Fitch公司(紐交所:ANF)進行了覆蓋,給予跑贏大盤評級,並宣佈了180美元的目標價。Abercrombie & Fitch的股價在週四收盤時爲149.95美元。看看其他分析師如何看待這隻股票。
  • 瑞銀分析師Danielle Antalffy對glaukos公司(紐交所:GKOS)進行了覆蓋,給予買入評級,並宣佈了182美元的目標價。glaukos的股價在週四收盤時爲135.70美元。看看其他分析師如何看待這隻股票。

Considering buying STZ stock? Here's what analysts think:

考慮購買STZ股票嗎?這是分析師的想法:

big

Read This Next:

Read This Next:

  • Dow Takes A Breather After Record Close, Dips Over 200 Points Ahead Of Jobs Report: Fear Index Remains In 'Greed' Zone
  • 道瓊斯指數在創紀錄收盤後稍作調整,因就業報告前下跌超過200點:恐懼指數仍處於『貪婪』區間

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論